Research output per year
Research output per year
Personal profile
Education/Academic qualification
Clinical Fellowship, Harvard University
Jul 1 1998 → Jun 30 2000
Award Date: Jun 30 2000
Ophthalmology, Residency, Harvard University
Jul 1 1995 → Jun 30 1998
Award Date: Jun 30 1998
Internship, Harvard University
Jun 1 1993 → Jun 30 1994
Award Date: Jun 30 1994
MD, Stanford University
Jan 1 1989 → Jun 13 1993
Award Date: Jun 13 1993
Research Area Keywords
- Clinical Care
- Clinical Translation & Trials
Fingerprint
Dive into the research topics where Rosa Y. Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial
Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy Study Group, Dec 2019, In: Ophthalmology Retina. 3, 12, p. 1076-1086 11 p.Research output: Contribution to journal › Article › peer-review
34 Scopus citations -
Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17
Age-Related Eye Disease Study 2 Research Group, Feb 2019, In: Ophthalmology. 126, 2, p. 261-273 13 p.Research output: Contribution to journal › Article › peer-review
23 Scopus citations -
Randomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year Outcomes
TREX-DME Study Group, Jun 2019, In: American Journal of Ophthalmology. 202, p. 91-99 9 p.Research output: Contribution to journal › Article › peer-review
36 Scopus citations -
Comparison of monthly vs treat-and-extend regimens for individuals with macular edema who respond well to anti-vascular endothelial growth factor medications: Secondary outcomes from the SCORE2 randomized clinical trial
SCORE2 Investigator Group, Apr 2018, In: JAMA Ophthalmology. 136, 4, p. 337-345 9 p.Research output: Contribution to journal › Article › peer-review
Open Access20 Scopus citations -
Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema
Diabetic Retinopathy Clinical Research Network, Jul 1 2018, In: Ophthalmology. 125, 7, p. 1054-1063 10 p.Research output: Contribution to journal › Article › peer-review
22 Scopus citations